The Valley Desk

ArticleCancer cellPublished

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer cell
Published
Subject terms
T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Lymphoma, Follicular; Immunotherapy; Immunotherapy, Adoptive; Clinical Trials as Topic; Lymphoma, Large B-Cell, Diffuse; Tumor Microenvironment; Enhancer of Zeste Homolog 2 Protein
PubMed ID
39642889
PubMed Central ID
PMC11732734
Added to directory
Source checked

Report a correction or request removal